CDER Releases Guidance Agenda for 2005

The FDA's Center for Drug Evaluation and Research (CDER) is planning to develop nearly 50 new guidances this year, including recommendations on direct-to-consumer advertising and product labeling, according to CDER's recently released guidance agenda.

The agenda includes 47 guidance topics related to advertising, clinical/medical developments, pharmacology, compliance, labeling and procedures. To view CDER's 2005 guidance agenda, go to http://www.fda.gov/cder/guidance/CY05Agenda-51005finalver.pdf (http://www.fda.gov/cder/guidance/CY05Agenda-51005finalver.pdf).